Unlocking cognition by Pulsatile GnRH in Alzheimer's DiseasE

The UPGRADE project aims to enhance cognitive performance in Alzheimer's patients by testing the safety and efficacy of pulsatile GnRH therapy based on promising preclinical results.

Subsidie
€ 150.000
2023

Projectdetails

Introduction

Cognitive decline associated with Alzheimer disease (AD) and other age-related dementias affects ~55 million people worldwide, and is a growing problem in aging European societies. However, most drugs fail at clinical trials, and approved treatments aimed at controlling or reversing pathological changes in the brain do not improve cognition in patients, besides having significant side effects. It is thus essential to design and test alternative approaches to enhance cognitive performance and reduce the personal, familial, and societal burden of AD.

Background

There is abundant circumstantial evidence pointing to a correlation between cognitive decline or AD progression with the age-dependent loss or deregulation of gonadotropin-releasing hormone (GnRH), a neuropeptide better known for its role in the reproductive axis. Nevertheless, a link between the two processes has not been seriously considered.

Recent Findings

In a recent groundbreaking study, we have shown that AD-like cognitive deficits in Down syndrome stem from progressive GnRH loss. Restoring native GnRH in a physiologically relevant pulsatile pattern using implantable pumps safely and effectively improves cognition long after the onset of symptoms, together with augmented brain connectivity.

Tanycytes and Their Role

Additionally, we have shown that tanycytes, specialized hypothalamic glial cells that control GnRH secretion, are fragmented in AD patient brains. Putting these two findings together, we hypothesize that cognitive performance in AD patients can also be enhanced by administering pulsatile GnRH at normally occurring doses, improving their quality of life.

Project Goals

The UPGRADE project will:

  1. Extend promising results we have obtained on the effectiveness of this strategy in a preclinical mouse model of AD.
  2. Analyze GnRH activity and pulsatility in an existing cohort of AD patients.
  3. Draft a clinical trial protocol to test the safety and efficacy of pulsatile GnRH therapy to reactivate cognitive reserves in patients with mild/moderate AD.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 150.000
Totale projectbegroting€ 150.000

Tijdlijn

Startdatum1-10-2023
Einddatum31-3-2025
Subsidiejaar2023

Partners & Locaties

Projectpartners

  • INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALEpenvoerder

Land(en)

France

Vergelijkbare projecten binnen European Research Council

ERC STG

MANUNKIND: Determinants and Dynamics of Collaborative Exploitation

This project aims to develop a game theoretic framework to analyze the psychological and strategic dynamics of collaborative exploitation, informing policies to combat modern slavery.

€ 1.497.749
ERC STG

Elucidating the phenotypic convergence of proliferation reduction under growth-induced pressure

The UnderPressure project aims to investigate how mechanical constraints from 3D crowding affect cell proliferation and signaling in various organisms, with potential applications in reducing cancer chemoresistance.

€ 1.498.280
ERC STG

Uncovering the mechanisms of action of an antiviral bacterium

This project aims to uncover the mechanisms behind Wolbachia's antiviral protection in insects and develop tools for studying symbiont gene function.

€ 1.500.000
ERC STG

The Ethics of Loneliness and Sociability

This project aims to develop a normative theory of loneliness by analyzing ethical responsibilities of individuals and societies to prevent and alleviate loneliness, establishing a new philosophical sub-field.

€ 1.025.860

Vergelijkbare projecten uit andere regelingen

ERC STG

Neuroprosthetic Modulation of Large-Scale Brain Networks for Treating Memory Disorders

This project aims to develop a neuromodulation framework using a neuroprosthesis to enhance learning and memory by manipulating neural oscillations in the hippocampus-prefrontal cortex circuit.

€ 1.499.625
ERC COG

Circadian rhythm: from preclinical to post-diagnosis dementia

The RHYTHM IN DEMENTIA project aims to identify circadian rhythm features linked to dementia risk and progression, using accelerometry and biomarkers to inform prevention strategies.

€ 1.999.982
ERC COG

Altitude-like hypoxia cognition training to target brain erythropoietin as a novel mechanism of long-lasting enhancement of neuroplasticity and cognitive functions

ALTIBRAIN aims to explore the effects of low ambient oxygen on brain EPO levels to enhance neuroplasticity and cognitive function, potentially transforming treatments for cognitive decline.

€ 1.999.944
EIC Pathfinder

Opto-Electronic Neural Connectoid Model Implemented for Neurodegenerative Disease

The project aims to develop a novel human brain-organoid model, called connectoids, to replace animal testing for Parkinson's disease, enhancing therapy monitoring and reducing societal burdens.

€ 2.992.203